Hormone therapy for menopause is a risk-benefit conversation, not a default, and the exam tests whether you can have it accurately. These questions cover assessing vasomotor symptoms, who is and is not a candidate for hormone therapy, route and formulation choices, evidence-based non-hormonal alternatives, and the bone and cardiovascular considerations that come with the transition. All 10 questions carry full rationales, written to the Family Nurse Practitioner (FNP-BC / FNP-C) blueprint.
Question 1
A 42-year-old female presents complaining of heavy and severely painful menstrual periods that have progressively worsened over the last two years. On bimanual examination, the nurse practitioner palpates a globular and boggy symmetrically enlarged uterus. Which of the following is the most accurate clinical assessment?
- A) Diagnose the patient with an endometrial polyp.
- B) Reassure regarding normal perimenopausal hormonal fluctuation changes.
- C) Suspect the presence of multiple uterine leiomyomas.
- D) Evaluate the patient for probable uterine adenomyosis.✓
💡 Key Takeaway
A boggy, symmetrically enlarged, and tender uterus in a patient with heavy, painful menses is the classic presentation of adenomyosis.
Show rationale
The classic clinical presentation of adenomyosis includes increasingly heavy menstrual bleeding and severe dysmenorrhea, typically accompanied by a boggy enlarged uterus on bimanual physical examination. This condition occurs when endometrial glands and stroma grow abnormally into the uterine myometrium. Suspecting multiple uterine leiomyomas (Option C) is a reasonable differential, as fibroids also cause heavy bleeding and uterine enlargement; however, a fibroid uterus typically feels firm and irregularly contoured, rather than globular and boggy. Diagnosing an endometrial polyp (Option A) is incorrect because polyps generally cause painless intermenstrual spotting without significant uterine enlargement or severe cramping. Reassuring the patient (Option B) is entirely inappropriate because her severe pain and distinct structural uterine changes require proper clinical evaluation, imaging, and management, rather than simple attribution to normal perimenopausal hormonal fluctuations.
Question 2
A 36-year-old female presents with no menses for 4 months, severe vaginal dryness, and hot flashes. She has a negative urine pregnancy test in the clinic today. Which of the following is the most appropriate action?
- A) Diagnose premature menopause based on her clinical symptoms.
- B) Reassure her that skipped periods are entirely normal.
- C) Order a serum prolactin level and pelvic ultrasound.
- D) Evaluate serum follicle-stimulating hormone and estradiol levels.✓
💡 Key Takeaway
Amenorrhea with vasomotor symptoms in women under 40 requires laboratory evaluation for premature ovarian insufficiency.
Show rationale
In a 36-year-old female experiencing amenorrhea and vasomotor symptoms, premature ovarian insufficiency must be carefully evaluated. Unlike typical perimenopause in older women, diagnosis in women under 40 requires laboratory confirmation. Option D is correct because elevated follicle-stimulating hormone and low estradiol levels help confirm this diagnosis. Option A is incorrect because clinical symptoms alone are insufficient for diagnosis under age 40. Option B is incorrect because having no menses for 4 months at this age is highly abnormal. Option C misses the primary hormonal evaluation needed to identify early ovarian failure.
Question 3
A 45-year-old female presents reporting irregular menses for 6 months and occasional hot flashes. She requests a blood test to determine if she is officially in menopause. Which of the following is the most appropriate action?
- A) Order a serum follicle-stimulating hormone level.
- B) Diagnose perimenopause based on her clinical symptoms.✓
- C) Obtain a serum estradiol and luteinizing hormone.
- D) Diagnose menopause based on her menstrual history.
💡 Key Takeaway
Perimenopause in women over 45 is a clinical diagnosis that does not require routine hormonal laboratory testing.
Show rationale
Perimenopause in a 45-year-old female is a clinical diagnosis based on menstrual irregularity and vasomotor symptoms. Routine laboratory testing is not recommended because hormone levels fluctuate wildly during this transition. Option A and C are incorrect because follicle-stimulating hormone and estradiol testing do not reliably diagnose perimenopause and are generally unnecessary in this age group. Option D is incorrect because menopause requires 12 consecutive months of amenorrhea, whereas she has only had irregular menses for 6 months. Therefore, establishing the diagnosis clinically is the most appropriate and evidence-based approach.
Question 4
A 48-year-old female presents with irregular menses and severe hot flashes. She also reports recent unintentional weight loss and palpitations. Which subjective inquiry is most critical to differentiate her vasomotor symptoms from other etiologies?
- A) Asking about the daily frequency of her hot flashes.
- B) Inquiring about recent changes in her daily bowel habits.✓
- C) Assessing for the presence of severe vaginal tissue dryness.
- D) Determining her maternal family history of severe osteoporosis.
💡 Key Takeaway
Unintentional weight loss and palpitations during perimenopause require assessing for hyperthyroidism as a symptom mimic.
Show rationale
During the perimenopause transition women often experience classic vasomotor symptoms like hot flashes and palpitations. However the presence of recent unintentional weight loss should immediately raise suspicion for an underlying endocrine disorder such as hyperthyroidism. Inquiring about changes in bowel habits such as diarrhea helps further differentiate thyroid dysfunction from standard perimenopause. Asking about the frequency of hot flashes or vaginal dryness focuses only on expected menopause symptoms without addressing the red flag of weight loss. Determining family history of osteoporosis is important for long term health maintenance but does not help diagnose the acute symptom presentation. As an advanced practice nurse you must always consider thyroid disease when assessing midlife women because the symptoms frequently overlap with the vasomotor symptoms of menopause.
Question 5
A 29-year-old pregnant patient uses intermediate-acting NPH insulin at bedtime for gestational diabetes. She reports waking up with night sweats and tremors around 3:00 AM, and her log shows a morning fasting glucose of 115 mg/dL. Which modification to the plan of care is most appropriate?
- A) Increase the evening dose of the intermediate NPH insulin.
- B) Discontinue the evening dose of the intermediate NPH insulin.
- C) Add a protein and complex carbohydrate evening bedtime snack.✓
- D) Switch the evening NPH insulin to a morning dosing.
💡 Key Takeaway
Nocturnal hypoglycemia with rebound morning hyperglycemia requires adding a balanced bedtime snack to stabilize overnight glucose.
Show rationale
The patient is experiencing the Somogyi effect, where nocturnal hypoglycemia triggers a counterregulatory hormone release, resulting in rebound morning hyperglycemia. Adding a balanced bedtime snack prevents the middle-of-the-night drop without requiring immediate medication adjustments. Increasing the NPH dose would dangerously worsen the nocturnal hypoglycemia. Discontinuing the insulin entirely is too drastic and may lead to uncontrolled fasting hyperglycemia. Switching to morning dosing would leave the patient without necessary basal insulin coverage overnight.
Question 6
A 55-year-old female reports severe hot flashes primarily occurring at night that cause significant sleep disruption. She has a contraindication to hormone therapy.
- A) Start oral clonidine administered in the morning
- B) Start oral venlafaxine administered at bedtime
- C) Start oral gabapentin administered at bedtime✓
- D) Start oral paroxetine administered in the morning
💡 Key Takeaway
Gabapentin is an effective non-hormonal option for vasomotor symptoms that also improves sleep quality.
Show rationale
Gabapentin (Option C) is an effective non-hormonal treatment for vasomotor symptoms, and its primary side effect of somnolence makes it highly beneficial for patients whose hot flashes cause nighttime awakenings. Clonidine (Option A) is generally less effective for hot flashes and can cause daytime hypotension. Venlafaxine (Option B) and paroxetine (Option D) are effective for vasomotor symptoms but can cause insomnia or activation, making them suboptimal choices for administration at bedtime in a patient already struggling with severe sleep disruption.
Question 7
A 53-year-old female requests non-hormonal treatment for severe hot flashes. She has a history of deep vein thrombosis and is considering fezolinetant.
- A) Order a baseline hepatic function panel✓
- B) Order a baseline fasting lipid profile
- C) Order a baseline pelvic transvaginal ultrasound
- D) Order a baseline dual x-ray absorptiometry
💡 Key Takeaway
Fezolinetant requires baseline and periodic hepatic function monitoring due to the risk of liver injury.
Show rationale
Fezolinetant is a neurokinin 3 receptor antagonist used for vasomotor symptoms, but it carries a known risk of hepatotoxicity. Therefore, checking a hepatic function panel (Option A) is required before initiation, with periodic monitoring at three, six, and nine months. A fasting lipid profile (Option B) is relevant when initiating oral estrogen but is not specifically required for fezolinetant. Pelvic ultrasounds (Option C) and DEXA scans (Option D) are useful for evaluating postmenopausal bleeding and bone density, respectively, but are not indicated for initiating this specific non-hormonal medication.
Question 8
A 50-year-old female presents with severe hot flashes affecting her quality of life. She underwent a total abdominal hysterectomy three years ago for benign uterine fibroids. Which intervention is most appropriate?
- A) Prescribe oral estrogen without any added daily progestin.✓
- B) Prescribe oral estrogen combined with a daily progestin.
- C) Prescribe an oral selective serotonin reuptake inhibitor daily.
- D) Prescribe a topical vaginal estrogen cream applied nightly.
💡 Key Takeaway
Women who have undergone a hysterectomy should receive estrogen-only therapy for the management of vasomotor symptoms.
Show rationale
For women experiencing severe hot flashes who have undergone a total abdominal hysterectomy, the standard of care is estrogen-only therapy. The primary purpose of adding progestin to a hormone replacement regimen is to prevent endometrial hyperplasia and cancer. Since this patient no longer has a uterus, she does not need endometrial protection, making Option A the correct choice. Option B is incorrect because adding unnecessary progestin exposes the patient to an increased risk of breast cancer and adverse cardiovascular events without offering any clinical benefit. Option C is incorrect because while SSRIs are a valid non-hormonal alternative, estrogen is the most effective first-line treatment for vasomotor symptoms in women without contraindications. Option D is incorrect because topical vaginal estrogen treats localized genitourinary symptoms but does not provide adequate systemic levels to relieve severe hot flashes.
Question 9
A 52-year-old female reports severe hot flashes and states she recently started bleeding again after nine months of complete amenorrhea. Which subjective inquiry is most crucial to guide the immediate clinical evaluation?
- A) The exact volume and duration of the recent vaginal bleeding.✓
- B) The frequency and intensity of her daily severe hot flashes.
- C) Her adherence to routine annual cervical cancer screening exams.
- D) Her current daily use of over-the-counter herbal phytoestrogens.
💡 Key Takeaway
Any unexpected bleeding during the late perimenopause transition requires detailed assessment to rule out endometrial pathology.
Show rationale
Although this patient has not quite reached the twelve month mark required for a formal menopause diagnosis her report of having started bleeding again after nine months of amenorrhea is highly suspicious. The late perimenopause transition is a high risk time for endometrial hyperplasia and cancer. Determining the exact volume and duration of the vaginal bleeding is the most critical next step to decide if an endometrial biopsy or pelvic ultrasound is urgently needed. Assessing the frequency of her hot flashes is important for comfort but does not address the potential risk of malignancy. Cervical cancer screening adherence and phytoestrogen use are relevant to her overall gynecological history but they do not triage the acute symptom of unexpected bleeding.
Question 10
A 35-year-old male who recently emigrated from Southeast Asia presents with a chronic cough, night sweats, and weight loss. His chest X-ray reveals patchy infiltrates in the posterior apical segments of the upper lobes. What is the most appropriate initial management step based on this interpretation?
- A) Prescribe oral azithromycin and schedule a follow-up chest radiograph.
- B) Initiate empiric levofloxacin and order a comprehensive metabolic panel.
- C) Place the patient in airborne isolation and order mycobacterial cultures.✓
- D) Administer intramuscular ceftriaxone and refer for urgent pulmonary consultation.
💡 Key Takeaway
Apical infiltrates in patients with tuberculosis risk factors require immediate airborne isolation and mycobacterial testing.
Show rationale
The combination of systemic symptoms, a history of recent emigration from an endemic area, and apical infiltrates is highly suspicious for active pulmonary tuberculosis rather than typical community-acquired pneumonia. The most appropriate initial step is to place the patient in airborne isolation and order mycobacterial cultures to prevent transmission and confirm the diagnosis. Prescribing oral azithromycin or initiating empiric levofloxacin treats typical or atypical bacterial pneumonia but inappropriately delays tuberculosis diagnosis and risks community spread. Furthermore, fluoroquinolones can partially treat tuberculosis, masking symptoms and promoting drug resistance. Administering intramuscular ceftriaxone is appropriate for severe typical pneumonia but fails to address the high likelihood of a mycobacterial infection in this specific clinical context.
